|
|
|
|
| Calendar |
|
/ March 12: Life Sciences GPDR Prep Forum / |
|
Philadelphia, PA |
|
/ March 13–14: Pharmaceutical Compliance Congress Asia / |
|
Shanghai, China |
|
/ March 15–16: Speaker Programs 2018 / |
|
Philadelphia, PA |
|
/ March 19–22: DCAT Week ‘18 / |
|
New York, NY |
|
/ March 25–28: 14th Annual Pharma Forum / |
|
Philadelphia, PA |
|
/ April 10–12: LogiPharma 2018 / |
|
Montreux, Switzerland |
|
/ May 10–11: Pharma Marketing Summit / |
|
Palm Beach, FL |
|
/ June 14–15: American Biomanufacturing Summit / |
|
San Francisco, CA |
|
/ October 2–3: American Pharma Outsourcing Summit / |
|
Philadelphia, PA |
|
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
|
National Harbor, MD |
|
|
|
| Industry update |
| //STORM Therapeutics (Cambridge, UK) appointed Nobel Prize Winner Professor Thomas Cech as a Scientific Advisor. //Concept Life Sciences (Manchester, UK) appointed Helen McKeever as Program Manager for the Group, and named David Halverson as US Head of Sales. //Sotirios G. Stergiopoulos was named Chief Medical Officer of Ipsen (Paris, France). He will retain his existing position as Senior Vice President, Head of Global Medical Affairs at the company. //Innate Pharma (Marseille, France) announced that Professor Eric Vivier joined the company as Chief Scientific Officer and Senior Vice President.//Dr. Peter Fellner resigned from his position as Chairman of Ablynx (Ghent, Belgium) last month. His successor is Dr. Bo Jesper Hansen, who has been a Non-Executive Director of the company since November 2013.//VBL Therapeutics (Tel Aviv, Israel) announced the appointments of both David Hastings and Susan Kelley, M.D. to its Board of Directors.//
|
|
|
|
